
Creon and diabetes: how pancreatic enzymes affect blood sugar control
Quick answer
Some people with diabetes have pancreatic exocrine insufficiency (PEI), where the pancreas does not make enough digestive enzymes. Food is then poorly absorbed and blood glucose can fluctuate. Creon replaces those enzymes when taken with food, which can help steady blood glucose in people with PEI.
Reviewed October 2026
Achieving good blood glucose control in people with type 1 and type 2 diabetes reduces complications. People whose blood glucose control is not good develop complications like heart attack, stroke, blindness, kidney problems, amputations and many more. It is therefore important to get blood glucose control within the target range. Life expectancy is reduced on average by 20 years in people with type 1 diabetes and up to 10 years in people with type 2 diabetes, based on a Department of Health paper (National Service Framework for Diabetes: Standards) published in 2001.
HbA1c, or glycosylated haemoglobin, is a measure of blood glucose levels. Ideally HbA1c should be less than 53 mmol/mol. However, a significant number of people have poor blood glucose control. We know that people with diabetes who had poor blood glucose control had complications with coronavirus infection (COVID-19). According to one study, risk was higher in those with an HbA1c above 58 mmol/mol, and illness and mortality increased as HbA1c levels increased.
What are the current treatment options for diabetes?
In people with diabetes, in addition to lowering blood glucose, it is important to get cholesterol and blood pressure controlled. There are several treatment options for lowering blood glucose in people with type 2 diabetes, which include:
- Metformin
- Sulphonylureas (gliclazide, glimepiride)
- DPP-4 inhibitors (sitagliptin, linagliptin, vildagliptin, saxagliptin)
- Glitazones (pioglitazone)
- SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin, ertugliflozin)
- Other hormone-based treatments
- Insulins
People with type 1 diabetes require insulin not only to control blood glucose but also for their survival.
What is considered when starting diabetes treatment?
When your doctor or nurse is planning to start a treatment to control blood glucose, or to change the dose, they look at:
- Age
- Duration of diabetes
- Body Mass Index (BMI)
- Risk of hypoglycaemia (very low blood glucose)
- Presence of kidney failure
Despite keeping these factors in mind while prescribing medications for diabetes, a significant number of people do not benefit from them and their blood glucose control (glycaemic control) remains sub-optimal.
Why does blood glucose stay high on the correct medicines?
The medications for diabetes mentioned above either affect insulin secretion directly or indirectly, overcome insulin resistance (pioglitazone, metformin) or get rid of excess sugar in the urine (SGLT2 inhibitors). None of these drugs have an impact on how much sugar is absorbed from the intestines.
In addition, none of these drugs exactly mimic the action of the several hormones in the body.
Why do complications develop despite good HbA1c?
The yardstick for good blood glucose control is HbA1c, which indicates the average blood glucose over the last 3–4 months. HbA1c does not, however, tell us whether blood glucose has been fluctuating. Some people have blood glucose that changes from day to day or even hour to hour — varying from 5 to 20 mmol/L despite eating the same food and doing similar activity.
Wide fluctuation in blood glucose is known to cause damage to the organs in the body, more so the blood vessels. Fluctuation in blood glucose is the reason for complications in some people who have an HbA1c around 53 mmol/mol.
What is pancreatic exocrine insufficiency (PEI)?
The pancreas is an important organ situated behind the stomach. Its functions divide into endocrine (hormonal) and exocrine (digestive). As an endocrine organ it produces several hormones including insulin, glucagon, pancreatic polypeptide and somatostatin.
As part of the digestive system, the pancreas produces digestive juices secreted through the pancreatic duct into the intestine. The important exocrine enzymes are lipase, which breaks down fats; protease, which breaks down protein; and amylase, which breaks down carbohydrates.
Any condition that affects the pancreas can affect production of these enzymes and lead to exocrine insufficiency. Symptoms can include:
- Steatorrhoea — stool that is greasy, frothy, pale and foul smelling
- Weight loss
- Blood glucose fluctuation
- Tiredness
- Bloating or abdominal pain
- Loss of muscle mass
- Vitamin A, D, E and K deficiency
- Skin, hair, bone and nail problems
Who can get PEI?
Several conditions affect the ability of the pancreas to produce the enzymes needed for digestion. These include:
- Gastric bypass surgery for weight loss
- Dumping syndrome
- Coeliac disease
- Cystic fibrosis
- Chronic pancreatitis
- Pancreatectomy (removal of the pancreas)
- Pancreatic cancer
- Diabetes
- Autoimmune pancreatitis
In most of these conditions the pancreas is affected by inflammation or cancer and cannot produce sufficient enzymes. Inflammation of the pancreas (pancreatitis) is also seen in people who drink excessive amounts of alcohol and in those with gallstones.
How does PEI lead to poor blood glucose control?
The food we eat combines carbohydrates, fats, proteins, dairy and fibre. To break these down the body needs enzymes, most importantly pancreatic lipase, amylase and protease. When these enzymes are insufficient, food cannot be digested properly; it moves on to the large intestine and is excreted. This is called malabsorption.
Complex carbohydrates in bread, rice, pasta and fruit must be broken down to simple sugars by amylase before they can be absorbed. In exocrine insufficiency they are not broken down and absorbed, so blood glucose can be low and occasionally fluctuate.
As soon as food enters the mouth, a great many hormonal and neurological messages pass between the gut and the brain, and the pancreas prepares insulin for the sugar that is expected. When the food is not absorbed properly, the insulin already released can lower glucose so far that it causes unpleasant effects and hypoglycaemia — blood glucose below 4 mmol/L (72 mg/dl). The liver then converts its glycogen stores to glucose, raising blood sugar again. This causes the fluctuation that leads to poor glycaemic control.
PEI also causes fat and protein malabsorption, leading to low muscle mass. People with PEI tend to have a low body mass index and low muscle mass, and because muscle is the organ that burns calories, low muscle mass can lead to poor carbohydrate metabolism.
How does Creon help?
PEI is diagnosed from symptoms, blood tests and a stool test.
Creon capsules replace the enzymes (amylase, lipase and protease) that the pancreas is not producing in sufficient amounts. It is recommended that Creon is taken every time you eat if you have PEI.
Make an appointment with your doctor:
- If you have any of the symptoms mentioned above
- If you suspect you have pancreatic exocrine insufficiency
- If your blood glucose is not well controlled despite taking all the medications for diabetes
Always consult your doctor before you start any new medication.
Key takeaways
- HbA1c shows average glucose but not how much it swings; wide fluctuation itself can damage blood vessels.
- Standard diabetes medicines do not affect how much sugar is absorbed from the gut.
- Pancreatic exocrine insufficiency causes malabsorption, which can make blood glucose unstable.
- PEI is diagnosed with symptoms, blood tests and a stool test; Creon replaces the missing enzymes with each meal.
Frequently asked questions
Who is at risk of pancreatic exocrine insufficiency?
People who have had gastric bypass surgery, and those with dumping syndrome, coeliac disease, cystic fibrosis, chronic or autoimmune pancreatitis, pancreatic cancer, removal of the pancreas, or diabetes.
When should Creon be taken?
It is recommended that Creon is taken every time you eat if you have PEI. Always consult your doctor before starting it.
Related insights
Dr Rajeswaran’s homepageThe London Obesity Clinic

Clinical insight
Why am I not losing weight on levothyroxine?
Read the article →
Clinical insight
Hypoactive sexual desire disorder (HSDD) in women: causes and treatment
Read the article →
Clinical insight
DEXA scan: what it measures, what the results mean, and when you need one
Read the article →
Clinical insight
Hyponatraemia (low sodium): symptoms, causes and when to worry
Read the article →
Clinical insight


